Immunespec
1 known investors
ImmuneSpec provides immunopeptidomics (MHC-associated peptide proteomics, MAPPs) analysis services used to identify T cell epitopes and assess the immunogenicity risk of biotherapeutics. It serves biotherapeutic developers and researchers, supporting the ranking and selection of drug candidates during early preclinical phases.
Investors · 1
Frequently asked questions
- What does Immunespec do?
- ImmuneSpec provides immunopeptidomics (MHC-associated peptide proteomics, MAPPs) analysis services used to identify T cell epitopes and assess the immunogenicity risk of biotherapeutics. It serves biotherapeutic developers and researchers, supporting the ranking and selection of drug candidates during early preclinical phases.
- Who are Immunespec's investors?
- Immunespec's investors include Heran Partners.